Cas no 7143-82-0 (3-methyl-1H-pyridazin-6-one;hydrate)
3-methyl-1H-pyridazin-6-one;hydrate Chemical and Physical Properties
Names and Identifiers
-
- 3(2H)-Pyridazinone,6-methyl-, hydrate (1:1)
- 3-methyl-1H-pyridazin-6-one,hydrate
- 6-METHYL-2,3-DIHYDROPYRIDAZIN-3-ONE HYDRATE
- 6-Methylpyridazin-3(2H)-one hydrate
- 6-methyl-2H-pyridazin-3-one Hydrate
- 6-methylpyridazin-3-ol hydrate
- 6-methylpyridazin-3-one hydrate
- SBB085719
- 3-methyl-1H-pyridazin-6-one hydrate
- RP00867
- OR21483
- 6-Methylpyridazin-3(2H);-one hydrate
- AK154828
- 6-methyl-2-hydropyridazin-3-one, hydrate
- AX8109630
- Y9893
- 6-Methylpyridazin-3(2H)-one--w
- 3-methyl-1H-pyridazin-6-one;hydrate
- 7143-82-0
- P14675
- 6-methylpyridazin-3(2H)-one monohydrate
- SY098444
- AS-52268
- MFCD00150586
- DTXSID80379140
- 3(2H)-Pyridazinone,6-methyl-,hydrate(1:1)
- J-518883
- AKOS026749756
- Compound 7.H~2~O
- FT-0621210
- A866442
- CS-0050159
- 6-Methylpyridazin-3(2H)-one--water (1/1)
- DB-055524
-
- MDL: MFCD28501205
- Inchi: 1S/C5H6N2O.H2O/c1-4-2-3-5(8)7-6-4;/h2-3H,1H3,(H,7,8);1H2
- InChI Key: DPIVSCHNBCFVEA-UHFFFAOYSA-N
- SMILES: O=C1C=CC(C)=NN1.O
Computed Properties
- Exact Mass: 128.05900
- Monoisotopic Mass: 128.058577502g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 169
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 42.5
Experimental Properties
- Melting Point: 112-116 oC
- PSA: 54.98000
- LogP: 0.01400
3-methyl-1H-pyridazin-6-one;hydrate Security Information
- Hazard Statement: Irritant
-
Hazardous Material Identification:
3-methyl-1H-pyridazin-6-one;hydrate Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
3-methyl-1H-pyridazin-6-one;hydrate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ON534-20g |
3-methyl-1H-pyridazin-6-one;hydrate |
7143-82-0 | 95% | 20g |
311.0CNY | 2021-08-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ON534-5g |
3-methyl-1H-pyridazin-6-one;hydrate |
7143-82-0 | 95% | 5g |
108.0CNY | 2021-08-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ON534-1g |
3-methyl-1H-pyridazin-6-one;hydrate |
7143-82-0 | 95% | 1g |
55.0CNY | 2021-08-04 | |
| Chemenu | CM104370-100g |
6-methylpyridazin-3-ol hydrate |
7143-82-0 | 97% | 100g |
$228 | 2021-08-06 | |
| TRC | M341036-1g |
6-Methylpyridazin-3(2H)-one Hydrate |
7143-82-0 | 1g |
$ 50.00 | 2022-06-03 | ||
| TRC | M341036-5g |
6-Methylpyridazin-3(2H)-one Hydrate |
7143-82-0 | 5g |
$ 65.00 | 2022-06-03 | ||
| TRC | M341036-10g |
6-Methylpyridazin-3(2H)-one Hydrate |
7143-82-0 | 10g |
$ 80.00 | 2022-06-03 | ||
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD109630-5g |
6-Methylpyridazin-3(2H)-one hydrate |
7143-82-0 | 95% | 5g |
¥54.0 | 2024-04-18 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD109630-25g |
6-Methylpyridazin-3(2H)-one hydrate |
7143-82-0 | 95% | 25g |
¥186.0 | 2024-04-18 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD109630-100g |
6-Methylpyridazin-3(2H)-one hydrate |
7143-82-0 | 95% | 100g |
¥613.0 | 2024-04-18 |
3-methyl-1H-pyridazin-6-one;hydrate Suppliers
3-methyl-1H-pyridazin-6-one;hydrate Related Literature
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
Additional information on 3-methyl-1H-pyridazin-6-one;hydrate
3-Methyl-1H-Pyridazin-6-One; Hydrate (CAS No. 7143-82-0): A Comprehensive Overview
The compound 3-Methyl-1H-Pyridazin-6-One; Hydrate (CAS No. 7143-82-0) is a fascinating organic molecule with significant potential in various fields of chemistry and materials science. This compound belongs to the class of pyridazine derivatives, which are known for their unique electronic properties and structural versatility. Recent advancements in synthetic methodologies and computational modeling have shed new light on the synthesis, characterization, and applications of this compound.
Pyridazine derivatives like 3-Methyl-1H-Pyridazin-6-One; Hydrate have garnered considerable attention due to their role as building blocks in drug discovery and materials science. The presence of the methyl group at the 3-position and the ketone group at the 6-position introduces a unique electronic environment, making this compound highly reactive under specific conditions. This reactivity has been exploited in the development of novel pharmaceutical agents and advanced materials.
Recent studies have focused on the synthesis of 3-Methyl-1H-Pyridazin-6-One; Hydrate through various routes, including cyclization reactions and directed metallation strategies. These methods not only enhance the yield but also provide insights into the stereochemical control of the molecule. The hydrate form of this compound is particularly interesting due to its improved solubility and stability under aqueous conditions, which makes it suitable for biological applications.
The physical and chemical properties of 3-Methyl-1H-Pyridazin-6-One; Hydrate have been extensively studied using advanced spectroscopic techniques such as NMR, IR, and UV-vis spectroscopy. These studies reveal that the compound exhibits strong absorption bands in the visible region, indicating its potential as a chromophore in optoelectronic devices. Additionally, its thermal stability has been evaluated, showing that it retains its structural integrity up to moderate temperatures, making it suitable for high-throughput screening processes.
In terms of applications, 3-Methyl-1H-Pyridazin-6-One; Hydrate has shown promise in the field of drug delivery systems. Its ability to form stable complexes with metal ions has led to its use as a ligand in metallo-drug design. Furthermore, recent research highlights its potential as an inhibitor of key enzymes involved in neurodegenerative diseases, such as Alzheimer's disease. The compound's ability to cross the blood-brain barrier has been validated through in vitro assays, underscoring its potential as a lead compound for drug development.
The hydrate form of 3-Methyl-1H-Pyridazin-6-One also exhibits interesting properties in materials science. Its incorporation into polymer matrices has been shown to enhance the mechanical and electrical properties of the resulting materials. This makes it a valuable component in the development of advanced composites for aerospace and automotive industries.
Recent advancements in computational chemistry have enabled researchers to predict the electronic properties and reactivity of 3-Methyl-1H-Pyridazin-6-One; Hydrate with unprecedented accuracy. Density functional theory (DFT) calculations have revealed that the molecule possesses a conjugated π-system that facilitates electron delocalization, contributing to its high reactivity and stability.
In conclusion, 3-Methyl-1H-Pyridazin-6-One; Hydrate (CAS No. 7143-82-0) is a versatile compound with a wide range of applications across multiple disciplines. Its unique chemical structure, combined with its favorable physical properties, positions it as a key player in both academic research and industrial applications. As research continues to uncover new insights into its synthesis, characterization, and functionality, this compound is poised to make significant contributions to the fields of chemistry, pharmacology, and materials science.
7143-82-0 (3-methyl-1H-pyridazin-6-one;hydrate) Related Products
- 13327-27-0(3-methyl-1H-pyridazin-6-one)
- 5468-36-0(2,3,5,6,7,8-hexahydrocinnolin-3-one)
- 108749-03-7(2,3,5,6,7,8-hexahydrocinnolin-3-one hydrobromide)
- 679405-98-2(3(2H)-Pyridazinone, 6-methyl-5-propyl- (9CI))
- 73619-57-5(6-Methylpyridazin-3-one)
- 570416-36-3(6-Isopropyl-3-pyridazinone)
- 94248-99-4(3-methyl-1H-pyridazin-6-one;hydrobromide)
- 7007-92-3(4,6-dimethyl-2,3-dihydropyridazin-3-one)
- 90175-93-2(6-(Aminomethyl)pyridazin-3(2H)-one hydrochloride)
- 933734-91-9(6-Hydroxypyridazine-3-carboxaldehyde)